DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20192754

Pattern of adverse drug reactions in paediatric patients reported to adverse drug reaction monitoring centre in a tertiary care hospital

Veereswara Rao Kurma, Triveni Manchu, Meena Kumari Amancharla, Kalyani Manchu, Pavan Kumar Kandula

Abstract


Background: Adverse drug reactions (ADRs) are an important cause of morbidity and mortality across the world and contribute to a significant economic burden on healthcare resources and community. In children, monitoring ADRs is essential as adequate clinical trials are lacking in this group. So, this study was undertaken to assess the ADR pattern in a paediatric population in a tertiary care hospital.

Methods: A cross sectional, retrospective study was done at ADR monitoring centre (AMC) for a period of 3 years in a tertiary care hospital. All the ADRs reported by the Department of Paediatrics to AMC were collected and analyzed for age group affected, demographic profile, ADR pattern, drug group, systems affected, causality and severity of the ADR.

Results: During the study period, a total of 102 ADRs were reported to the AMC from the paediatric department. Out of 102 ADRs reported, males represented 60.8% and females represented 39.2%. Maximum number of ADRs were seen in the age group of 1-5 years (43.3%). Most common ADR reported was maculopapular rash (27.5%) followed by diarrhoea (14.7%). The most common drug class causing ADRs are antibiotics (36.3%) followed by anticonvulsants (18.6%). Vaccines contributed to 14.7% of all reported ADRs. Majority of the ADRs were of probable (70.6%) causality and moderate (52%) in severity.

Conclusions: ADRs were reported more among under 5 years of age and antibiotics were the common implicated causative agents. Most of the reactions were of moderate severity. Information acquired through ADR reporting may be useful in identifying and minimizing preventable ADRs and augmenting the knowledge of the prescribers to deal with ADRs more efficiently.


Keywords


Adverse drug reaction, Causality, Paediatric, Pharmacovigilance

Full Text:

PDF

References


Roussillon LC, Pouyanne P, Haramburu F, Miremont G, B├ęgaud B. Incidence of serious adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther. 2001;69(6):458-62.

Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, et al. Which drugs cause preventable admissions to hospital?. A systematic review. Br J Clin Pharmacol. 2007;63:136-47.

Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, et al. Adverse drug reactions in children-a systematic review. PLoS One. 2012;7(3):1-24.

Sharma PK, Misra AK, Gupta N, Khera D, Gupta A, Khera P. Pediatric pharmacovigilance in an institute of national importance: journey has just begun. Indian J Pharmacol. 2017;49:390-5.

WHO. Pharmacovigilance. Available at: https://www.who.int/medicines/areas/quality-_safety/safety_efficacy/pharmavigi/en/. Accessed April 18 2019.

Patel TK, Patel PB. Incidence of adverse drug reactions in indian hospitals: a systematic review of prospective studies. Curr Drug Saf. 2016;11(2):128-36

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital - Their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687-92.

Thota P, Thota A, Medhi B, Sidhu S, Kumar P, Selvan VK, Singh GN. Drug safety alerts of pharmacovigilance programme of India: a scope for targeted spontaneous reporting in India. Perspectives Clin Res. 2018;9(1):51.

Posthumus AAG, Alingh CCW, Zwaan CCM. Adverse drug reaction related admissions in paediatrics, a prospective single-centre study. BMJ Open. 2012;2:e000934.

World Health Organization (WHO)-Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment. Available at: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf . Accessed 18 April 2019.

Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a South Indian hospital-Their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687-92.

Murthy SN, Jose PV, Basalingappa S, Ali SK, Elizabeth MVK. Adverse drug reactions in hospitalized paediatric patients in a tertiary care center in Kerala, India. Int J Basic Clin Pharmacol. 2018;7:1998-2004.

Digra. Pattern of adverse drug reactions in children attending the department of pediatrics in a tertiary care center: a prospective observational study. clinical medicine insights. Pediatrics. 2015;9:73-8.

Priyadharsini R, Surendiran A, Aadithan C, Sreenivasan S, Sahoo FK. A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother. 2011;2(4):277-80.

Reena V, Jyotsna V, Nitin V, Parag S, Niket R. A study of adverse drug reactions in paediatric age group with assessment of causality, severity and preventabilty in a tertiary care hospital. J Dent Med Sci. 2014;13(5):42-8.

Arulmani R, Rajendra SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2008;65:210-6.

Staltari O, Cilurzo F, Caroleo B, Greco A, Corasaniti F. Annual report on adverse events related with vaccines use in Calabria (Italy). J Pharmacol Pharmacother. 2013;4(1):S61-5.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a South Indian hospital-Their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687-92.

Shamna M, Dilip C, Ajmal M, Mohan LP, Shinu C, Jafer CP, et al. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital. Saudi Pharmaceut J. 2014;22(4):303-8.

Singh H, Dulhani N, Kumar BN, Singh P, Tewari P, Nayak K. A pharmacovigilance study in medicine department of tertiary care hospital in Chhattisgarh, Jagdalpur, India. J Young Pharm. 2010;2(1):95-100.